I think Dr. J.is playing this information dissemination perfectly. The FDA understands keeping shareholders informed but may very well look askance if some of these things that have happened are touted to the masses. It has taken time and conversation to repair the lines of communication between CYDY and the FDA and Dr. J. isn't going to screw that up by releasing something as a PR that the FDA might not be appreciative of before being released before its time.
This letter is masterful and shows everybody, including the FDA that adults are planning and running the show now. Very good things are coming as Leronlimab will be able to start showing what it can do.